Kymera Therapeutics, Inc. (KYMR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 6.57B |
| Enterprise Value | 6.29B |
| P/E Ratio | -37.15 |
| PEG Ratio | 10.79 |
| Price/Sales Ratio | 112.61 |
| Price/Book Ratio | 8.36 |
| Enterprise/Revenue | 109.71 |
| Enterprise/EBITDA | -32.86 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -3.42 |
| Operating Margin | -3.96 |
| Return On Assets | -0.2 |
| Return On Equity | -0.22 |
| Revenue | 39.2M |
| Revenue/Share | 1.02 |
| Gross Profit | 39.2M |
| EBITDA | -303.06M |
| Net Income | -311.4M |
| Diluted EPS | -3.69 |
| Total Cash | 971.21M |
| Total Cash/Share | 9.7 |
| Total Debt | 76.6M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 11.13 |
| Book Value Per Share | 16.13 |
| 52-Week Change | 112.25 |
| 52-Week High | 142.92 |
| 52-Week Low | 61.5 |
| Moving Average 50 Days | 116.75 |
| Moving Average 200 Days | 98.9 |
| Average Volume | 825,617 |
| Shares Outstanding | 85.37M |
| % Held by Institutions | 100.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |